. | Albumin ≥3 g/dl (N = 173) . | Albumin <3 g/dl (N = 56) . | P-value . |
---|---|---|---|
Preoperative recipient characteristics | |||
Male sex | 129 (74.6) | 38 (67.9) | 0.387 |
Age (years) | 55.1 ± 10.8 | 55.3 ± 11 | 0.904 |
BMI (kg/m2) | 25.8 ± 4.5 | 25.4 ± 4.7 | 0.614 |
Smoker | 45 (26.2) | 12 (21.4) | 0.594 |
Diabetes | 32 (18.7) | 18 (32.1) | 0.042 |
Arterial hypertension | 98 (57) | 32 (57.1) | >0.999 |
Pulmonary hypertension | 14 (8.1) | 7 (12.5) | 0.424 |
Prior cardiothoracic surgery | 101 (58.4) | 44 (78.6) | 0.007 |
LVAD | 78 (45.1) | 37 (66.1) | 0.009 |
ICM | 73 (42.4) | 25 (44.6) | 0.877 |
DCM | 81 (47.1) | 28 (50) | 0.759 |
ARVC | 7 (4.1) | 1 (1.8) | 0.683 |
RCM | 0 (0) | 1 (1.8) | 0.246 |
HCM | 3 (1.7) | 1 (1.8) | >0.999 |
Myocarditis | 2 (1.2) | 0 (0) | >0.999 |
Preoperative dialysis | 10 (5.8) | 2 (3.7) | 0.736 |
IMPACT score | 8.1 ± 4.7 | 9.4 ± 4.1 | 0.096 |
Albumin (g/dl) | 3.9 ± 0.7 | 3.7 ± 0.7 | 0.185 |
MELD score | 14.3 ± 7.6 | 13.7 ± 6.5 | 0.652 |
Donor characteristics | |||
Male sex | 98 (56.6) | 28 (50) | 0.441 |
Age (years) | 43.1 ± 12.2 | 44.3 ± 12.4 | 0.526 |
BMI (kg/m²) | 26.1 ± 4.9 | 26.0 ± 3.7 | 0.945 |
Cardiopulmonary resuscitation | 53 (30.6) | 15 (26.8) | 0.618 |
Intraoperative characteristics (min) | |||
Duration of surgery | 401 ± 95 | 490 ± 148 | <0.001 |
Duration of CPB | 240 ± 57 | 294 ± 94 | <0.001 |
Total ischaemia time | 212 ± 48 | 220 ± 51 | 0.330 |
PRBC (l) | 2.9 ± 2.4 | 4.9 ± 3.2 | <0.001 |
Platelets (l) | 1.0 ± 0.8 | 1.5 ± 1.1 | 0.001 |
FFP (l) | 1.5 ± 1.6 | 1.9 ± 2.3 | 0.218 |
Postoperative laboratory values | |||
Creatinine (mg/dl) | 1.5 ± 0.8 | 1.3 ± 0.5 | 0.230 |
Bilirubin (mg/dl) | 2.6 ± 1.9 | 2.5 ± 1.3 | 0.576 |
INR | 1.2 ± 1.9 | 1.3 ± 2.2 | 0.280 |
Albumin (g/dl) | 3.5 ± 0.4 | 2.4 ± 0.4 | <0.001 |
Postoperative characteristics | |||
ECMO | 33 (19.2) | 28 (50) | <0.001 |
Renal replacement therapy | 90 (57.7) | 35 (62.5) | 0.635 |
MELD score | 14.6 ± 5.3 | 14.3 ± 5.1 | 0.711 |
Albumin substitution within first 24 h | 47 (28.7) | 29 (54.7) | 0.001 |
Days in ICU | 24 ± 25 | 25 ± 26 | 0.677 |
Duration of mechanical ventilation (hours) | 110 ± 167 | 223 ± 216 | 0.001 |
30-day mortality | 6 (3.5) | 12 (21.4) | <0.001 |
1-year mortality | 18 (10.4) | 22 (39.3) | <0.001 |
. | Albumin ≥3 g/dl (N = 173) . | Albumin <3 g/dl (N = 56) . | P-value . |
---|---|---|---|
Preoperative recipient characteristics | |||
Male sex | 129 (74.6) | 38 (67.9) | 0.387 |
Age (years) | 55.1 ± 10.8 | 55.3 ± 11 | 0.904 |
BMI (kg/m2) | 25.8 ± 4.5 | 25.4 ± 4.7 | 0.614 |
Smoker | 45 (26.2) | 12 (21.4) | 0.594 |
Diabetes | 32 (18.7) | 18 (32.1) | 0.042 |
Arterial hypertension | 98 (57) | 32 (57.1) | >0.999 |
Pulmonary hypertension | 14 (8.1) | 7 (12.5) | 0.424 |
Prior cardiothoracic surgery | 101 (58.4) | 44 (78.6) | 0.007 |
LVAD | 78 (45.1) | 37 (66.1) | 0.009 |
ICM | 73 (42.4) | 25 (44.6) | 0.877 |
DCM | 81 (47.1) | 28 (50) | 0.759 |
ARVC | 7 (4.1) | 1 (1.8) | 0.683 |
RCM | 0 (0) | 1 (1.8) | 0.246 |
HCM | 3 (1.7) | 1 (1.8) | >0.999 |
Myocarditis | 2 (1.2) | 0 (0) | >0.999 |
Preoperative dialysis | 10 (5.8) | 2 (3.7) | 0.736 |
IMPACT score | 8.1 ± 4.7 | 9.4 ± 4.1 | 0.096 |
Albumin (g/dl) | 3.9 ± 0.7 | 3.7 ± 0.7 | 0.185 |
MELD score | 14.3 ± 7.6 | 13.7 ± 6.5 | 0.652 |
Donor characteristics | |||
Male sex | 98 (56.6) | 28 (50) | 0.441 |
Age (years) | 43.1 ± 12.2 | 44.3 ± 12.4 | 0.526 |
BMI (kg/m²) | 26.1 ± 4.9 | 26.0 ± 3.7 | 0.945 |
Cardiopulmonary resuscitation | 53 (30.6) | 15 (26.8) | 0.618 |
Intraoperative characteristics (min) | |||
Duration of surgery | 401 ± 95 | 490 ± 148 | <0.001 |
Duration of CPB | 240 ± 57 | 294 ± 94 | <0.001 |
Total ischaemia time | 212 ± 48 | 220 ± 51 | 0.330 |
PRBC (l) | 2.9 ± 2.4 | 4.9 ± 3.2 | <0.001 |
Platelets (l) | 1.0 ± 0.8 | 1.5 ± 1.1 | 0.001 |
FFP (l) | 1.5 ± 1.6 | 1.9 ± 2.3 | 0.218 |
Postoperative laboratory values | |||
Creatinine (mg/dl) | 1.5 ± 0.8 | 1.3 ± 0.5 | 0.230 |
Bilirubin (mg/dl) | 2.6 ± 1.9 | 2.5 ± 1.3 | 0.576 |
INR | 1.2 ± 1.9 | 1.3 ± 2.2 | 0.280 |
Albumin (g/dl) | 3.5 ± 0.4 | 2.4 ± 0.4 | <0.001 |
Postoperative characteristics | |||
ECMO | 33 (19.2) | 28 (50) | <0.001 |
Renal replacement therapy | 90 (57.7) | 35 (62.5) | 0.635 |
MELD score | 14.6 ± 5.3 | 14.3 ± 5.1 | 0.711 |
Albumin substitution within first 24 h | 47 (28.7) | 29 (54.7) | 0.001 |
Days in ICU | 24 ± 25 | 25 ± 26 | 0.677 |
Duration of mechanical ventilation (hours) | 110 ± 167 | 223 ± 216 | 0.001 |
30-day mortality | 6 (3.5) | 12 (21.4) | <0.001 |
1-year mortality | 18 (10.4) | 22 (39.3) | <0.001 |
ARVC, arrhythmogenic right ventricular cardiomyopathy; BMI, body mass index; CPB, cardiopulmonary bypass; DCM, dilative cardiomyopathy; ECMO; extracorporeal membrane oxygenation; FFP, fresh frozen plasma; HCM, hypertrophic cardiomyopathy; ICM, ischaemic cardiomyopathy; IMPACT, risk index for mortality prediction after cardiac transplantation; ICU, intensive care unit; INR, international normalized ratio; LVAD, left ventricular assist device; MELD, model for end-stage liver disease; PRBC, packed red blood cells; RCM, restrictive cardiomyopathy [11].
Significant results are marked in bold.
. | Albumin ≥3 g/dl (N = 173) . | Albumin <3 g/dl (N = 56) . | P-value . |
---|---|---|---|
Preoperative recipient characteristics | |||
Male sex | 129 (74.6) | 38 (67.9) | 0.387 |
Age (years) | 55.1 ± 10.8 | 55.3 ± 11 | 0.904 |
BMI (kg/m2) | 25.8 ± 4.5 | 25.4 ± 4.7 | 0.614 |
Smoker | 45 (26.2) | 12 (21.4) | 0.594 |
Diabetes | 32 (18.7) | 18 (32.1) | 0.042 |
Arterial hypertension | 98 (57) | 32 (57.1) | >0.999 |
Pulmonary hypertension | 14 (8.1) | 7 (12.5) | 0.424 |
Prior cardiothoracic surgery | 101 (58.4) | 44 (78.6) | 0.007 |
LVAD | 78 (45.1) | 37 (66.1) | 0.009 |
ICM | 73 (42.4) | 25 (44.6) | 0.877 |
DCM | 81 (47.1) | 28 (50) | 0.759 |
ARVC | 7 (4.1) | 1 (1.8) | 0.683 |
RCM | 0 (0) | 1 (1.8) | 0.246 |
HCM | 3 (1.7) | 1 (1.8) | >0.999 |
Myocarditis | 2 (1.2) | 0 (0) | >0.999 |
Preoperative dialysis | 10 (5.8) | 2 (3.7) | 0.736 |
IMPACT score | 8.1 ± 4.7 | 9.4 ± 4.1 | 0.096 |
Albumin (g/dl) | 3.9 ± 0.7 | 3.7 ± 0.7 | 0.185 |
MELD score | 14.3 ± 7.6 | 13.7 ± 6.5 | 0.652 |
Donor characteristics | |||
Male sex | 98 (56.6) | 28 (50) | 0.441 |
Age (years) | 43.1 ± 12.2 | 44.3 ± 12.4 | 0.526 |
BMI (kg/m²) | 26.1 ± 4.9 | 26.0 ± 3.7 | 0.945 |
Cardiopulmonary resuscitation | 53 (30.6) | 15 (26.8) | 0.618 |
Intraoperative characteristics (min) | |||
Duration of surgery | 401 ± 95 | 490 ± 148 | <0.001 |
Duration of CPB | 240 ± 57 | 294 ± 94 | <0.001 |
Total ischaemia time | 212 ± 48 | 220 ± 51 | 0.330 |
PRBC (l) | 2.9 ± 2.4 | 4.9 ± 3.2 | <0.001 |
Platelets (l) | 1.0 ± 0.8 | 1.5 ± 1.1 | 0.001 |
FFP (l) | 1.5 ± 1.6 | 1.9 ± 2.3 | 0.218 |
Postoperative laboratory values | |||
Creatinine (mg/dl) | 1.5 ± 0.8 | 1.3 ± 0.5 | 0.230 |
Bilirubin (mg/dl) | 2.6 ± 1.9 | 2.5 ± 1.3 | 0.576 |
INR | 1.2 ± 1.9 | 1.3 ± 2.2 | 0.280 |
Albumin (g/dl) | 3.5 ± 0.4 | 2.4 ± 0.4 | <0.001 |
Postoperative characteristics | |||
ECMO | 33 (19.2) | 28 (50) | <0.001 |
Renal replacement therapy | 90 (57.7) | 35 (62.5) | 0.635 |
MELD score | 14.6 ± 5.3 | 14.3 ± 5.1 | 0.711 |
Albumin substitution within first 24 h | 47 (28.7) | 29 (54.7) | 0.001 |
Days in ICU | 24 ± 25 | 25 ± 26 | 0.677 |
Duration of mechanical ventilation (hours) | 110 ± 167 | 223 ± 216 | 0.001 |
30-day mortality | 6 (3.5) | 12 (21.4) | <0.001 |
1-year mortality | 18 (10.4) | 22 (39.3) | <0.001 |
. | Albumin ≥3 g/dl (N = 173) . | Albumin <3 g/dl (N = 56) . | P-value . |
---|---|---|---|
Preoperative recipient characteristics | |||
Male sex | 129 (74.6) | 38 (67.9) | 0.387 |
Age (years) | 55.1 ± 10.8 | 55.3 ± 11 | 0.904 |
BMI (kg/m2) | 25.8 ± 4.5 | 25.4 ± 4.7 | 0.614 |
Smoker | 45 (26.2) | 12 (21.4) | 0.594 |
Diabetes | 32 (18.7) | 18 (32.1) | 0.042 |
Arterial hypertension | 98 (57) | 32 (57.1) | >0.999 |
Pulmonary hypertension | 14 (8.1) | 7 (12.5) | 0.424 |
Prior cardiothoracic surgery | 101 (58.4) | 44 (78.6) | 0.007 |
LVAD | 78 (45.1) | 37 (66.1) | 0.009 |
ICM | 73 (42.4) | 25 (44.6) | 0.877 |
DCM | 81 (47.1) | 28 (50) | 0.759 |
ARVC | 7 (4.1) | 1 (1.8) | 0.683 |
RCM | 0 (0) | 1 (1.8) | 0.246 |
HCM | 3 (1.7) | 1 (1.8) | >0.999 |
Myocarditis | 2 (1.2) | 0 (0) | >0.999 |
Preoperative dialysis | 10 (5.8) | 2 (3.7) | 0.736 |
IMPACT score | 8.1 ± 4.7 | 9.4 ± 4.1 | 0.096 |
Albumin (g/dl) | 3.9 ± 0.7 | 3.7 ± 0.7 | 0.185 |
MELD score | 14.3 ± 7.6 | 13.7 ± 6.5 | 0.652 |
Donor characteristics | |||
Male sex | 98 (56.6) | 28 (50) | 0.441 |
Age (years) | 43.1 ± 12.2 | 44.3 ± 12.4 | 0.526 |
BMI (kg/m²) | 26.1 ± 4.9 | 26.0 ± 3.7 | 0.945 |
Cardiopulmonary resuscitation | 53 (30.6) | 15 (26.8) | 0.618 |
Intraoperative characteristics (min) | |||
Duration of surgery | 401 ± 95 | 490 ± 148 | <0.001 |
Duration of CPB | 240 ± 57 | 294 ± 94 | <0.001 |
Total ischaemia time | 212 ± 48 | 220 ± 51 | 0.330 |
PRBC (l) | 2.9 ± 2.4 | 4.9 ± 3.2 | <0.001 |
Platelets (l) | 1.0 ± 0.8 | 1.5 ± 1.1 | 0.001 |
FFP (l) | 1.5 ± 1.6 | 1.9 ± 2.3 | 0.218 |
Postoperative laboratory values | |||
Creatinine (mg/dl) | 1.5 ± 0.8 | 1.3 ± 0.5 | 0.230 |
Bilirubin (mg/dl) | 2.6 ± 1.9 | 2.5 ± 1.3 | 0.576 |
INR | 1.2 ± 1.9 | 1.3 ± 2.2 | 0.280 |
Albumin (g/dl) | 3.5 ± 0.4 | 2.4 ± 0.4 | <0.001 |
Postoperative characteristics | |||
ECMO | 33 (19.2) | 28 (50) | <0.001 |
Renal replacement therapy | 90 (57.7) | 35 (62.5) | 0.635 |
MELD score | 14.6 ± 5.3 | 14.3 ± 5.1 | 0.711 |
Albumin substitution within first 24 h | 47 (28.7) | 29 (54.7) | 0.001 |
Days in ICU | 24 ± 25 | 25 ± 26 | 0.677 |
Duration of mechanical ventilation (hours) | 110 ± 167 | 223 ± 216 | 0.001 |
30-day mortality | 6 (3.5) | 12 (21.4) | <0.001 |
1-year mortality | 18 (10.4) | 22 (39.3) | <0.001 |
ARVC, arrhythmogenic right ventricular cardiomyopathy; BMI, body mass index; CPB, cardiopulmonary bypass; DCM, dilative cardiomyopathy; ECMO; extracorporeal membrane oxygenation; FFP, fresh frozen plasma; HCM, hypertrophic cardiomyopathy; ICM, ischaemic cardiomyopathy; IMPACT, risk index for mortality prediction after cardiac transplantation; ICU, intensive care unit; INR, international normalized ratio; LVAD, left ventricular assist device; MELD, model for end-stage liver disease; PRBC, packed red blood cells; RCM, restrictive cardiomyopathy [11].
Significant results are marked in bold.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.